Freeze-drying/lyophilization can be defined as a critical process in pharmaceutical manufacturing, providing an effective strategy for stabilizing heat-sensitive biologics such as vaccines, monoclonal antibodies, and RNA therapeutics. This chapter focuses on the fundamental stages of the freeze-drying process including freezing, primary drying, and secondary drying along with parameters essential for product stability and moisture control. Advances such as controlled nucleation and innovative freeze-drying technologies are transforming the efficiency, scalability, and reproducibility of this process. The chapter also emphasizes cryoprotectant selection, detailing mechanisms that prevent ice crystallization and stabilize biomolecules. Various cryoprotectants, including natural, synthetic, and semi-synthetic options are discussed, with optimization strategies to enhance performance and minimize toxicity. Real-world applications and case studies illustrate their impact on pharmaceutical stability. Comprehensive characterization methods, including thermal analysis, spectroscopy, imaging, morphological evaluation, and residual moisture assessment, are explored to ensure product consistency and stability. The integration of automation, regulatory compliance, and scale-up challenges, emphasizing solutions for meeting industry standards. Emerging applications in biopharmaceuticals, such as mRNA therapeutics, CAR-T cell therapies, and personalized medicine, highlight the expanding role of lyophilization in advanced healthcare. By addressing the freeze-drying process, cryoprotectant science, characterization techniques, and future directions, this chapter provides a detailed analysis of lyophilization as a cornerstone in pharmaceutical and biopharmaceutical innovation.